Pennsylvania bill seeks clinical research on psychedelics
Mental Health Weekly – January 14, 2022
Source: OpenAlex
Summary
A significant development in **medicine** and **law** unfolded in Pennsylvania last fall with new **legislation** to fund **clinical trials** for **psilocybin**. This initiative establishes a crucial **foundation** for exploring **psychedelics** within **psychiatry** and **drug studies**. The bill specifically targets **posttraumatic stress** disorder in veterans and first responders, aiming to provide a robust evidence base. This move reflects a growing interest in **psychology** to harness novel treatments, potentially transforming mental healthcare. It underscores the evolving landscape of therapeutic possibilities.
Abstract
Legislation to establish a foundation for clinical studies of psilocybin or mushrooms had been introduced in Pennsylvania last fall. The bill would fund clinical trials to address post‐traumatic stress disorder (PTSD) in veterans and first responders.